Goldman Sachs
TLIS

Goldman Sachs’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Goldman Sachs’s Portfolio TLIS Stock Details TLIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,549
Closed -$19K – 5731
2022
Q2 		$19K Buy
+1,549
New +$19K ﹤0.01% 5436